| Organism name | Euphorbia helioscopia L. |
|---|---|
| Genus | Euphorbia |
| Family | Euphorbiaceae |
| Kingdom | Plantae |
| Linked NCBI taxonomy name | Euphorbia helioscopia |
|---|---|
| Linked NCBI taxonomy ID | 154990 |
| Linked level | species |
| Family in NCBI taxonomy | Euphorbiaceae |
|---|---|
| ID | 3977 |
| Kingdom (Superkingdom) in NCBI taxonomy | Viridiplantae |
|---|---|
| ID | 33090 |
| Plant class | rosids |
|---|---|
| ID | 71275 |
| KNApSAcK ID | name | ChEMBL link | CTD link |
# of proteins in
ChEMBL interaction / related OMIM / related KEGG DISEASE |
# of genes in
CTD interaction / related diseases |
KCF-S
cluster |
phytochemical
cluster |
figure |
|---|---|---|---|---|---|---|---|---|
|
C00009434
|
Glabrone
/ Eurycarpin B |
CHEMBL600457
|
1 / 5 / 3 | No. 24 | No. 15 |
|
||
|
C00029518
|
4',5,7-Trihydroxyflavanone
/ 5,7,4'-Trihydroxyflavanone |
CHEMBL9352
CHEMBL32571 |
57 / 46 / 40 | No. 25 | No. 14 |
|
||
|
C00006938
|
Licochalcone B
|
No. 92 | No. 13 |
|
||||
|
C00030506
|
Icariside B2
/ (-)-Icariside B2 |
No. 153 |
|
|||||
|
C00030468
|
Hemistepsin
|
No. 206 | No. 38 |
|
||||
|
C00030234
|
Euphornin C
|
No. 757 | No. 41 |
|
||||
|
C00030232
|
Euphornin
|
CHEMBL499921
|
No. 757 | No. 41 |
|
|||
|
C00030233
|
Euphornin B
|
CHEMBL463643
|
No. 757 | No. 41 |
|
|||
|
C00030231
|
Euphoheliosnoid D
|
No. 757 | No. 41 |
|
||||
|
C00030235
|
Euphoscopin A
|
No. 757 | No. 41 |
|
||||
|
C00030239
|
Euphoscopin J
|
No. 757 | No. 41 |
|
||||
|
C00030237
|
Euphoscopin C
|
CHEMBL506068
|
No. 757 | No. 41 |
|
|||
|
C00030238
|
Euphoscopin F
|
No. 757 | No. 41 |
|
||||
|
C00030236
|
Euphoscopin B
|
No. 757 | No. 41 |
|
||||
|
C00030230
|
Euphohelioscopin A
|
No. 1267 | No. 41 |
|
||||
|
C00030467
|
Helioscopinolide B
|
CHEMBL469645
CHEMBL451142 |
1 / 0 / 0 | No. 2372 |
|
|||
|
C00007057
|
Licochalcone A
|
CHEMBL139702
|
C070840
|
1 / 0 / 0 | 1 / 0 | No. 3383 |
|
| accession | description | class description | KNApSAcK metabolite in interactions |
# of diseases
(OMIM / KEGG) |
|---|---|---|---|---|
| P18031 | Tyrosine-protein phosphatase non-receptor type 1 | Tyr | C00007057 C00029518 C00030467 | 0 / 0 |
| P37231 | Peroxisome proliferator-activated receptor gamma | NR1C3 | C00009434 C00029518 | 5 / 3 |
| Q9NPD5 | Solute carrier organic anion transporter family member 1B3 | Electrochemical transporter | C00029518 | 1 / 0 |
| P22310 | UDP-glucuronosyltransferase 1-4 | Enzyme | C00029518 | 3 / 0 |
| P10635 | Cytochrome P450 2D6 | Cytochrome P450 2D6 | C00029518 | 1 / 0 |
| Q9Y6L6 | Solute carrier organic anion transporter family member 1B1 | Electrochemical transporter | C00029518 | 1 / 0 |
| O94956 | Solute carrier organic anion transporter family member 2B1 | Unclassified protein | C00029518 | 0 / 0 |
| Q9HAW8 | UDP-glucuronosyltransferase 1-10 | Enzyme | C00029518 | 0 / 0 |
| P35354 | Prostaglandin G/H synthase 2 | Oxidoreductase | C00029518 | 0 / 3 |
| P04062 | Glucosylceramidase | Enzyme | C00029518 | 6 / 4 |
| Q03181 | Peroxisome proliferator-activated receptor delta | NR1C2 | C00029518 | 0 / 0 |
| P62158 | Calmodulin | Unclassified protein | C00029518 | 1 / 0 |
| P47989 | Xanthine dehydrogenase/oxidase | Oxidoreductase | C00029518 | 1 / 1 |
| P04798 | Cytochrome P450 1A1 | Cytochrome P450 1A1 | C00029518 | 0 / 0 |
| P08183 | Multidrug resistance protein 1 | drug | C00029518 | 1 / 0 |
| P11712 | Cytochrome P450 2C9 | Cytochrome P450 2C9 | C00029518 | 0 / 1 |
| P24941 | Cyclin-dependent kinase 2 | Cdc2 | C00029518 | 0 / 0 |
| P24864 | G1/S-specific cyclin-E1 | Other cytosolic protein | C00029518 | 0 / 2 |
| O75828 | Carbonyl reductase [NADPH] 3 | Enzyme | C00029518 | 0 / 0 |
| P41145 | Kappa-type opioid receptor | Opioid receptor | C00029518 | 0 / 0 |
| P04278 | Sex hormone-binding globulin | Secreted protein | C00029518 | 0 / 0 |
| P36888 | Receptor-type tyrosine-protein kinase FLT3 | Pdgfr | C00029518 | 1 / 1 |
| P16152 | Carbonyl reductase [NADPH] 1 | Enzyme | C00029518 | 0 / 0 |
| O75496 | Geminin | Unclassified protein | C00029518 | 0 / 0 |
| P54855 | UDP-glucuronosyltransferase 2B15 | Enzyme | C00029518 | 0 / 0 |
| P41143 | Delta-type opioid receptor | Opioid receptor | C00029518 | 0 / 0 |
| Q92731 | Estrogen receptor beta | NR3A2 | C00029518 | 0 / 1 |
| P15121 | Aldose reductase | Enzyme | C00029518 | 0 / 0 |
| P33527 | Multidrug resistance-associated protein 1 | drugs | C00029518 | 0 / 0 |
| O94782 | Ubiquitin carboxyl-terminal hydrolase 1 | Enzyme | C00029518 | 0 / 0 |
| P04150 | Glucocorticoid receptor | NR3C1 | C00029518 | 0 / 1 |
| P11511 | Cytochrome P450 19A1 | Cytochrome P450 19A1 | C00029518 | 2 / 2 |
| P14061 | Estradiol 17-beta-dehydrogenase 1 | Enzyme | C00029518 | 0 / 0 |
| Q16678 | Cytochrome P450 1B1 | Cytochrome P450 1B1 | C00029518 | 4 / 4 |
| P04745 | Alpha-amylase 1 | Enzyme | C00029518 | 0 / 0 |
| P18054 | Arachidonate 12-lipoxygenase, 12S-type | Enzyme | C00029518 | 2 / 0 |
| P05177 | Cytochrome P450 1A2 | Cytochrome P450 1A2 | C00029518 | 0 / 0 |
| Q99714 | 3-hydroxyacyl-CoA dehydrogenase type-2 | Enzyme | C00029518 | 3 / 3 |
| Q9UNQ0 | ATP-binding cassette sub-family G member 2 | ATP binding cassette | C00029518 | 2 / 0 |
| Q92887 | Canalicular multispecific organic anion transporter 1 | Unclassified protein | C00029518 | 1 / 1 |
| Q9HAW9 | UDP-glucuronosyltransferase 1-8 | Enzyme | C00029518 | 0 / 0 |
| O76074 | cGMP-specific 3',5'-cyclic phosphodiesterase | PDE_5A | C00029518 | 0 / 0 |
| P03372 | Estrogen receptor | NR3A1 | C00029518 | 1 / 1 |
| P22303 | Acetylcholinesterase | Hydrolase | C00029518 | 1 / 0 |
| P35372 | Mu-type opioid receptor | Opioid receptor | C00029518 | 0 / 0 |
| P33261 | Cytochrome P450 2C19 | Cytochrome P450 2C19 | C00029518 | 1 / 1 |
| P37059 | Estradiol 17-beta-dehydrogenase 2 | Enzyme | C00029518 | 0 / 0 |
| P08684 | Cytochrome P450 3A4 | Cytochrome P450 3A4 | C00029518 | 0 / 1 |
| Q9UNA4 | DNA polymerase iota | Enzyme | C00029518 | 0 / 0 |
| P22309 | UDP-glucuronosyltransferase 1-1 | Enzyme | C00029518 | 5 / 1 |
| P10275 | Androgen receptor | NR3C4 | C00029518 | 3 / 4 |
| Q07869 | Peroxisome proliferator-activated receptor alpha | NR1C1 | C00029518 | 0 / 0 |
| Q04760 | Lactoylglutathione lyase | Enzyme | C00029518 | 0 / 0 |
| P49888 | Estrogen sulfotransferase | Enzyme | C00029518 | 0 / 0 |
| Q9NUW8 | Tyrosyl-DNA phosphodiesterase 1 | Enzyme | C00029518 | 1 / 1 |
| O00255 | Menin | Unclassified protein | C00029518 | 2 / 5 |
| Q03164 | Histone-lysine N-methyltransferase 2A | Enzyme | C00029518 | 1 / 2 |
| gene | gene name | gene description | KNApSAcK metabolite in interactions |
|---|---|---|---|
| 3553 | IL1B, IL-1, IL1-BETA, IL1F2 | interleukin 1, beta |
C00007057
|
| OMIM | preferred title | UniProt |
|---|---|---|
| #300438 | 17-beta-hydroxysteroid dehydrogenase x deficiency |
Q99714
|
| #300068 | Androgen insensitivity syndrome; ais |
P10275
|
| #312300 | Androgen insensitivity, partial; pais |
P10275
|
| #613546 | Aromatase deficiency |
P11511
|
| #139300 | Aromatase excess syndrome; aexs |
P11511
|
| #601816 | Bilirubin, serum level of, quantitative trait locus 1; biliqtl1 |
P22309
|
| #614490 | Blood group, junior system; jr |
Q9UNQ0
|
| %606641 | Body mass index; bmi |
P37231
|
| #609338 | Carotid intimal medial thickness 1 |
P37231
|
| #114500 | Colorectal cancer; crc |
P18054
|
| #218800 | Crigler-najjar syndrome, type i |
P22309
P22310 |
| #606785 | Crigler-najjar syndrome, type ii |
P22309
P22310 |
| #609535 | Drug metabolism, poor, cyp2c19-related |
P33261
|
| #608902 | Drug metabolism, poor, cyp2d6-related |
P10635
|
| #237500 | Dubin-johnson syndrome; djs |
Q92887
|
| #133239 | Esophageal cancer |
P18054
|
| #615363 | Estrogen resistance; estrr |
P03372
|
| #608013 | Gaucher disease, perinatal lethal |
P04062
|
| #230800 | Gaucher disease, type i |
P04062
|
| #230900 | Gaucher disease, type ii |
P04062
|
| #231000 | Gaucher disease, type iii |
P04062
|
| #231005 | Gaucher disease, type iiic |
P04062
|
| #143500 | Gilbert syndrome |
P22309
P22310 |
| #137750 | Glaucoma 1, open angle, a; glc1a |
Q16678
|
| #231300 | Glaucoma 3, primary congenital, a; glc3a |
Q16678
|
| #137760 | Glaucoma, primary open angle; poag |
Q16678
|
| #137800 | Glioma susceptibility 1; glm1 |
P37231
|
| #605130 | Hairy elbows, short stature, facial dysmorphism, and developmental delay |
Q03164
|
| #237450 | Hyperbilirubinemia, rotor type; hblrr |
Q9NPD5
Q9Y6L6 |
| #237900 | Hyperbilirubinemia, transient familial neonatal; hblrtfn |
P22309
|
| #145000 | Hyperparathyroidism 1; hrpt1 |
O00255
|
| #612244 | Inflammatory bowel disease 13; ibd13 |
P08183
|
| #601626 | Leukemia, acute myeloid; aml |
P36888
|
| #604367 | Lipodystrophy, familial partial, type 3; fpld3 |
P37231
|
| #300705 | Mental retardation, x-linked 17; mrx17 |
Q99714
|
| #300220 | Mental retardation, x-linked, syndromic 10; mrxs10 |
Q99714
|
| #131100 | Multiple endocrine neoplasia, type i; men1 |
O00255
|
| #601665 | Obesity |
P37231
|
| #168600 | Parkinson disease, late-onset; pd |
P04062
|
| #604229 | Peters anomaly |
Q16678
|
| #313200 | Spinal and bulbar muscular atrophy, x-linked 1; smax1 |
P10275
|
| #607250 | Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy; scan1 |
Q9NUW8
|
| #138900 | Uric acid concentration, serum, quantitative trait locus 1; uaqtl1 |
Q9UNQ0
|
| #614916 | Ventricular tachycardia, catecholaminergic polymorphic, 4; cpvt4 |
P62158
|
| #278300 | Xanthinuria, type i |
P47989
|
| #112100 | Yt blood group antigen |
P22303
|
| KEGG | name | UniProt |
|---|---|---|
| H00033 | Adrenal carcinoma |
O00255
(related)
|
| H00034 | Carcinoid |
O00255
(related)
|
| H00045 | Malignant islet cell carcinoma |
O00255
(related)
|
| H00246 | Primary hyperparathyroidism |
O00255
(related)
|
| H01102 | Pituitary adenomas |
O00255
(related)
|
| H00026 | Endometrial Cancer |
P03372
(marker)
Q92731 (marker) |
| H00066 | Lewy body dementia (LBD) |
P04062
(related)
|
| H00126 | Gaucher disease |
P04062
(related)
|
| H00426 | Defects in the degradation of ganglioside |
P04062
(related)
|
| H00810 | Progressive myoclonic epilepsy (PME) |
P04062
(related)
|
| H00599 | 46,XX disorders of sex development (Disorders related to androgen excess) |
P04150
(related)
P11511 (related) |
| H00036 | Osteosarcoma |
P08684
(marker)
|
| H00024 | Prostate cancer |
P10275
(related)
|
| H00062 | Spinal and bulbar muscular atrophy (SBMA) |
P10275
(related)
|
| H00608 | 46,XY disorders of sex development (Disorders in androgen synthesis or action) |
P10275
(related)
|
| H00609 | 46,XY disorders of sex development (Other) |
P10275
(related)
|
| H00794 | Aromatase excess syndrome |
P11511
(related)
|
| H01205 | Coumarin resistance |
P11712
(related)
|
| H00208 | Hyperbilirubinemia |
P22309
(related)
Q92887 (related) |
| H00018 | Gastric cancer |
P24864
(related)
|
| H00055 | Laryngeal cancer |
P24864
(related)
|
| H01171 | Poor drug metabolism (PM) |
P33261
(related)
|
| H00017 | Esophageal cancer |
P35354
(related)
|
| H00025 | Penile cancer |
P35354
(related)
|
| H00046 | Cholangiocarcinoma |
P35354
(related)
|
| H00003 | Acute myeloid leukemia (AML) |
P36888
(related)
|
| H00032 | Thyroid cancer |
P37231
(related)
|
| H00409 | Type II diabetes mellitus |
P37231
(related)
|
| H00420 | Familial partial lipodystrophy (FPL) |
P37231
(related)
|
| H00192 | Xanthinuria |
P47989
(related)
|
| H00001 | Acute lymphoblastic leukemia (ALL) (precursor B lymphoblastic leukemia) |
Q03164
(related)
Q03164 (marker) |
| H00002 | Acute lymphoblastic leukemia (ALL) (precursor T lymphoblastic leukemia) |
Q03164
(related)
|
| H00612 | Primary open angle glaucoma |
Q16678
(related)
|
| H01075 | Peters anomaly |
Q16678
(related)
|
| H01159 | Anterior segment dysgenesis (ASD) |
Q16678
(related)
|
| H01203 | Primary congenital glaucoma (PCG) |
Q16678
(related)
|
| H00480 | Non-syndromic X-linked mental retardation |
Q99714
(related)
|
| H00658 | Syndromic X-linked mental retardation |
Q99714
(related)
|
| H00925 | 2-Methyl-3-hydroxybutyryl-CoA dehydrogenase (MHBD) deficiency |
Q99714
(related)
|
| H00063 | Spinocerebellar ataxia (SCA) |
Q9NUW8
(related)
|